Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Revenue

Concord Biotech had revenue of 2.78B INR in the quarter ending December 31, 2025, with 13.74% growth. This brings the company's revenue in the last twelve months to 11.59B, up 6.38% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.

• Revenue (ttm): 11.59B
• Revenue Growth: +6.38%
• P/S Ratio: 10.18
• Revenue / Employee: 7.38M
• Employees: 1,571
• Market Cap: 117.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	12.00B	1.83B	18.01%
Mar 31, 2024	10.17B	1.64B	19.20%
Mar 31, 2023	8.53B	1.40B	19.67%
Mar 31, 2022	7.13B	959.91M	15.56%
Mar 31, 2021	6.17B	1.05B	20.42%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error